Figure 4
Deletion of Tarsl2 exerts no effect on MSC integrity or tRNA aminoacylation in vivo.A, protein levels of various MSC components in the 6-week-old Tarsl2+/+ and Tarsl2−/− mouse muscle. B, incorporation of several MSC components in the 6-week-old Tarsl2+/+ and Tarsl2−/− mouse muscle lysates. C and D, levels of tRNAs [tRNALys(CUU), tRNAIle(AAU), tRNAGln(CUG), tRNAArg(ACG), and tRNALeu(AAG)] in the 6-week-old Tarsl2+/+ and Tarsl2−/− mouse muscle. E and F, aminoacylation levels of tRNALys(CUU) and tRNAIle(UAU) in the 6-week-old Tarsl2+/+ and Tarsl2−/− mouse muscle. De: tRNA deaminoacylation control. G and H, global protein synthesis rate of the 6-week-old Tarsl2+/+ and Tarsl2−/− mouse MEFs, as determined by puromycin incorporation assay. Gapdh was included as the loading control. Error bars in (D, F, and H) represent the mean ± SD with the p values indicated (two-tailed Student’s t test). MEF, mouse embryonic fibroblast; MSC, multiple tRNA synthetase complex.